1. Nguyen, Lap P, Tran, Si C, Suetsugu, Shiro, Lim, Yun-Sook, Hwang, Soon B. 2020. PACSIN2 Interacts with Nonstructural Protein 5A and Regulates Hepatitis C Virus Assembly. In Journal of virology, 94, . doi:10.1128/JVI.01531-19. https://pubmed.ncbi.nlm.nih.gov/31801866/
2. Franca, Raffaella, Stocco, Gabriele, Favretto, Diego, Decorti, Giuliana, Rabusin, Marco. 2019. PACSIN2 rs2413739 influence on thiopurine pharmacokinetics: validation studies in pediatric patients. In The pharmacogenomics journal, 20, 415-425. doi:10.1038/s41397-019-0130-0. https://pubmed.ncbi.nlm.nih.gov/31792371/
3. Dumont, Vincent, Tolvanen, Tuomas A, Kuusela, Sara, Kawachi, Hiroshi, Lehtonen, Sanna. 2017. PACSIN2 accelerates nephrin trafficking and is up-regulated in diabetic kidney disease. In FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 31, 3978-3990. doi:10.1096/fj.201601265R. https://pubmed.ncbi.nlm.nih.gov/28550045/
4. Stocco, Gabriele, Yang, Wenjian, Crews, Kristine R, Relling, Mary V, Evans, William E. 2012. PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicity. In Human molecular genetics, 21, 4793-804. doi:10.1093/hmg/dds302. https://pubmed.ncbi.nlm.nih.gov/22846425/